My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
November 2015
FROM THE PRESIDENT
The Year Ahead: Championing the ID Specialty
IDSA is moving forward on key priorities, from promoting the value of the ID specialist – e.g, in antimicrobial stewardship programs – to attracting new medical students and residents into the field. We’re up for the challenge, as the champions for our specialty.
TOP STORIES
IDWeek 2015 Recap

Thousands converged to San Diego Oct. 7-11 for the 4th annual IDWeek to gain a comprehensive understanding of current scientific discoveries, treatment, and prevention as well as to develop new contacts and resources. IDWeek 2015 reached a record attendance of 6,118 clinicians, epidemiologists, researchers, investigators, nurses, pharmacists, public health professionals, and more.

Efforts to Address Pyrimethamine Access Issues Continue
More than a month after committing to doing so, Turing Pharmaceuticals has not reduced the price of pyrimethamine (Daraprim). In response, led by HIVMA more than 150 organizations sent an appeal to Turing urging them to take immediate steps to address pricing and access issues. HIVMA, IDSA and others met with Turing executives on Nov. 3 to discuss the issues raised in the appeal.
New IDSA MOC Modules
IDSA has developed two new Maintenance of Certification (MOC) modules on adult vaccines, and travel and tropical medicine.  Learn more about the modules and how to register.
IDSA Journal Club

The Relevance of C. difficile Molecular Assays: Do They Overdiagnose Clinical Disease?
Maternal and Neonatal Consequences of Treated and Untreated Asymptomatic Bacteriuria in Pregnancy;
Champions of HIV Prevention: An Important Role for ID-Trained Specialists;
HIV PrEP in the Real World: More Promising Results;
Choose Wisely: Balancing Central Venous Catheter Complications in the Era of No Patient Harm


Upcoming dates to remember


The combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct. 26-30, 2016, in New Orleans. See you there!

PATIENT CARE AND SCIENCE
Hepatitis C Guidance Panel Recommends Direct-Acting Drugs for Nearly All Patients with Chronic Hepatitis C
Podcast Now Available for Guideline on Vertebral Osteomyelitis
CDC Launches Improved Online Foodborne Outbreak Search Tool
CLINICAL PRACTICE MANAGEMENT
CMS Urges Medicaid Programs to Assure Access to Hepatitis C Treatment
HIVMA Offers Resources for Providers During Open Enrollment
POLICY AND ADVOCACY
IDSA Continues to Advance ID Physician-Led Stewardship; You Can Get Involved in Efforts to Address AR
Congress Increases Budget for Health Programs, Challenges Remain
New Proposed Changes to Common Rule: IDSA Highlights ID Research Concerns
Proposed Diagnostics Regulations: IDSA Promotes Unique ID Concerns
Congressional Briefings Tout Benefits, Debunk Myths of Syringe Services Programs
GLOBAL ID
Science Speaks Covers Recent WHO Global TB Report and More
EDUCATION AND RESOURCES
HIVMA Clinical Fellowship Program: Dec. 31 Application Deadline
Scholarship Program Gives Medical Students a First-Hand Look at ID: $2,000 Scholarships Available
Make Your Donations to the IDSA Foundation and Get a Tax Deduction
Webinar: Learn More about Patient-Centered Outcomes Research
YOU AND YOUR COLLEAGUES
New IDSA Subcommittee Focuses on Interests of Fellows in Training
Members on the Move
Member Report
FROM THE PRESIDENT
The Year Ahead: Championing the ID Specialty
TOP STORIES
IDWeek 2015 Recap
Efforts to Address Pyrimethamine Access Issues Continue
New IDSA MOC Modules
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here